The Modern Role of Beta-Blockers in Cardiovascular Medicine

Front Cover
PMPH-USA, 2010 - Adrenergic beta blockers - 271 pages
The book provides a concise much-needed update of beta-blockers use cardiovascular area (particularly hypertension and heart failure). It will uncover the clinical inaccuracies of how the UK NICE Committee have "got it wrong" in their recent pronouncements on BBs and hypertension. Beta-blockers (BBs) are a large and important family of therapeutic agents with primary use is in cardiovascular medicine. The therapeutic areas that BB covers include: Ischemic Heart Disease, Hypertension, Heart Failure and Arrhythmias. Explanation of the role of BBs in the treatment of hypertension and why the UK Health Authority (The NICE Committee) have "got it wrong" A current update of the vital role of beta-blockers in the treatment of heart failure, and why some beta-blockers are "ineffective" Provides a total and current update of the role of beta-blockers in cardiovascular medicine.


BetaBlockers and their Effects upon Ischemic Heart Disease Peripheral Vascular Disease Noncardiac Surgery and the Atheromatous Process
BetaBlockers and Hypertension
BetaBlockers and Cardiac Arrhythmias
BetaBlockers and Heart Failure
Adverse Reactions

Other editions - View all

Common terms and phrases

About the author (2010)

John Malcolm Cruickshank M.D, Independent Cardiovascular consultant, University College Hospital, London; Withington Hospital, Manchester, UK.

Bibliographic information